MODALITY OF TISSUE BIOPSY AND MUTATIONAL ANALYSIS IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER: A SINGLE CENTRE AUDIT

被引：0
|
作者：
Moore, S. [1 ]
Murphy, M. [1 ]
Hukins, C. [1 ]
Loff, K. [1 ]
机构：
[1] Princess Alexandra Hosp, Resp & Sleep Med Dept, Brisbane, Qld, Australia
来源：
RESPIROLOGY | 2019年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP 104
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [21] Prospective comparison of liquid biopsy to standard of care tissue testing in metastatic, non-squamous, non-small cell lung cancer (NSCLC) patients (pts)
    Palmero, R.
    Taus, A.
    Majem Tarruella, M.
    Viteri, S.
    Costa, E. Carcereny
    Garde, J.
    Felip Font, E.
    Cassidy, C.
    Dix, D.
    Karachaliou, N.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
    Melosky, Barbara
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [23] THE ADMINISTRATION OF BEVACIZUMAB FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES
    Fukunaga, Kentaro
    Kawashima, Satoru
    Yoshihashi, Saiko
    Seto, Ruriko
    Kanda, Rie
    Higami, Yuichi
    Goto, Kenichi
    Ryujin, Yasushi
    Nakagawa, Hiroaki
    Van Tho, Nguyen
    Yamaguchi, Masafumi
    Oguma, Tetuya
    Nagao, Taishi
    Ogawa, Emiko
    Nakano, Yasutaka
    RESPIROLOGY, 2013, 18 : 87 - 87
  • [24] CARBOPLATIN AND PEMETREXED FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - OVERALL SURVIVAL AND TOXICITY
    Andersen, R.
    Mellemgaard, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S73 - S73
  • [25] Maintenance pemetrexed for non-squamous non-small cell lung cancer (NSCLC): 'real life' outcomes from a UK centre
    Lim, J.
    Neocleous, M.
    Coote, J.
    Woolf, D.
    Bayman, N.
    Lee, L.
    Sheikh, H.
    Blackhall, F.
    Califano, R.
    Summers, Y.
    LUNG CANCER, 2017, 103 : S30 - S31
  • [26] Repeated Biopsy for Immunohistochemical and Mutational Analysis of Non-Small Cell Lung Cancer: Feasibility and Safety
    Riudavets, Mariona
    Anguera, Georgia
    Torrego, Alfons
    Pajares, Virginia
    Gimenez, Ana
    Lopez Vilaro, Laura
    Martinez Tellez, Elisabeth
    Caries Trujillo, Joan
    Farre, Nuria
    Lerma, Enrique
    Belda, Josep
    Camacho, Valle
    Fernandez, Alejandro
    Munoz, Ana
    Majem, Margarita
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S529 - S529
  • [27] Meta-Analysis of Metformin in Combination with Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
    Marrone, K.
    Parikh, A.
    Becker, D.
    Brahmer, J.
    Ettinger, D.
    Levy, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S894 - S894
  • [28] Camrelizumab in patients with advanced non-squamous non-small cell lung cancer: a cost-effective analysis in China
    Xie, Qian
    Zheng, Hanrui
    Su, Na
    Li, Qiu
    BMJ OPEN, 2022, 12 (08):
  • [29] Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer
    Tetsuya Sakai
    Hibiki Udagawa
    Shingo Matsumoto
    Kiyotaka Yoh
    Kaname Nosaki
    Takaya Ikeda
    Yoshitaka Zenke
    Keisuke Kirita
    Seiji Niho
    Tetsuo Akimoto
    Koichi Goto
    Genichiro Ishii
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1227 - 1237
  • [30] A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer
    Panje, C. M.
    Dedes, K. J.
    Matter-Walstra, K.
    Schwenkglenks, M.
    Gautschi, O.
    Siano, M.
    Aebersold, D. M.
    Plasswilm, L.
    Lupatsch, J. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (06) : 588 - 588
12345